01.03.2016
- British drugmaker GlaxoSmithKline is said to have launched a search for a new CEO to replace Andrew Witty, who is now widely expected to step down at the latest by the end of 2017...
21.01.2015
- GlaxoSmithKline could consider more partial public share offerings for component units as it evolves in the coming years, potentially pointing to a break-up of the group if this...
